- Home
- DENN vs IVA Comparison
DENN vs IVA Comparison
Compare DENN & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DENN
- IVA
- Stock Information
- Founded
- DENN 1953
- IVA 2011
- Country
- DENN United States
- IVA France
- Employees
- DENN N/A
- IVA N/A
- Industry
- DENN Restaurants
- IVA Biotechnology: Pharmaceutical Preparations
- Sector
- DENN Consumer Discretionary
- IVA Health Care
- Exchange
- DENN Nasdaq
- IVA Nasdaq
- Market Cap
- DENN 203.4M
- IVA 162.8M
- IPO Year
- DENN 1989
- IVA 2020
- Fundamental
- Price
- DENN $3.87
- IVA $2.91
- Analyst Decision
- DENN Strong Buy
- IVA Strong Buy
- Analyst Count
- DENN 6
- IVA 4
- Target Price
- DENN $7.75
- IVA $13.25
- AVG Volume (30 Days)
- DENN 1.7M
- IVA 8.3K
- Earning Date
- DENN 04-29-2025
- IVA 03-26-2025
- Dividend Yield
- DENN N/A
- IVA N/A
- EPS Growth
- DENN 17.14
- IVA N/A
- EPS
- DENN 0.41
- IVA N/A
- Revenue
- DENN $452,334,000.00
- IVA $15,243,814.00
- Revenue This Year
- DENN $5.81
- IVA $18.05
- Revenue Next Year
- DENN $2.50
- IVA $46.74
- P/E Ratio
- DENN $9.44
- IVA N/A
- Revenue Growth
- DENN N/A
- IVA N/A
- 52 Week Low
- DENN $3.75
- IVA $1.53
- 52 Week High
- DENN $9.01
- IVA $3.98
- Technical
- Relative Strength Index (RSI)
- DENN 33.90
- IVA 51.16
- Support Level
- DENN $3.75
- IVA $2.70
- Resistance Level
- DENN $4.01
- IVA $3.10
- Average True Range (ATR)
- DENN 0.18
- IVA 0.19
- MACD
- DENN 0.06
- IVA -0.02
- Stochastic Oscillator
- DENN 24.00
- IVA 46.66
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.